AIDX 20/20 Biolabs, Inc.
NEUTRAL
Impact: 2/10
8-K
8-K context-dependent: Items 3.03
Latest settled — T+5d
AIDX ▼ -13.40% at T+5d
NEUTRAL call ✗ call lost -13.40% · α vs SPY -13.87% · entry $0.9700 → $0.8400
Currently $0.9600 · -1.03% from $0.9700 entry
T+1d
-2.06%
call -2.06% · α -2.61%
$0.9500
settled 17d ago
T+5d
-13.40%
call -13.40% · α -13.87%
$0.8400
settled 11d ago
T+20d
—
call — · α —
—
in 11d
T+60d
—
call — · α —
—
in 2mo
Price Chart
Loading chart...
Executive Summary
20/20 Biolabs, Inc. filed an 8-K reporting that its Board adopted Amendment No. 1 to the Bylaws, reducing the stockholder meeting quorum requirement from a majority to one-third of outstanding shares. This is a routine governance change with no financial impact.
Actionable Insight
This is a routine bylaw amendment with no trading implications. Monitor for any subsequent filings that may signal activist interest or capital structure changes, but no immediate action warranted.
Key Facts
- Board adopted Amendment No. 1 to Amended and Restated Bylaws on May 19, 2026.
- Quorum for stockholder meetings reduced from a majority to one-third of outstanding shares.
- No financial data, earnings, guidance, or material agreements disclosed.
Financial Impact
No financial impact — governance-only filing.
Risk Factors
- Lower quorum threshold could facilitate passage of shareholder proposals with less support, but no specific proposals are pending.
Market Snapshot
Exchange
Nasdaq
Sector
Services-Testing Laboratories
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-061039 |
| Document: ea029218001ex3-2.htm | 0001213900-26-061039 |
| Document: 0001213900-26-061039-index-headers.html | 0001213900-26-061039 |
| Document: 0001213900-26-061039-index.html | 0001213900-26-061039 |
| Document: 0001213900-26-061039.txt | 0001213900-26-061039 |
7 reports for AIDX
100%
Hit rate
best @ T+20▲ +37.42%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 26, 2026
17d ago
|
8-K
| $0.9700 $0.8400 | ▼ −13.40% | ▼ −13.87% | $0.9600 (−1.03%) |
|
May 20, 2026
23d ago
|
8-K
| $1.21 $0.9500 | ▲ +21.49% | ▲ +23.09% | $0.9600 (+20.66%) |
|
May 20, 2026
23d ago
|
Press Release
| $1.21 $0.9500 | ▲ +21.49% | ▲ +23.09% | $0.9600 (+20.66%) |
|
Apr 28, 2026
6w ago
|
8-K
| $1.55 $1.49 | ▲ +3.87% | ▲ +5.56% | $0.9600 (+38.06%) |
|
Apr 13, 2026
8w ago
|
EFFECT
| $1.85 $1.71 | ▼ −7.57% | ▼ −10.86% | $0.9600 (−48.11%) |
|
Mar 27, 2026
11w ago
|
Press Release
| $1.80 $2.02 | ▲ +12.22% | ▲ +8.36% | $0.9600 (−46.67%) |
|
Mar 24, 2026
11w ago
|
Press Release
| $1.64 $1.88 | ▲ +14.63% | ▲ +15.06% | $0.9600 (−41.46%) |
Showing 7 of 7
US Market Status
Market Closed — Opens Mon (45h 28m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access